Applied Clinical Trials podkast

ACT Brief: APAC Trial Advantages, Learning From Setbacks, and Sunharbo Stroke Prevention Approval

0:00
1:41
Do tyłu o 15 sekund
Do przodu o 15 sekund
In today’s ACT Brief, we examine why APAC is attractive for global Phase III programs, how clinical research professionals can turn a failed pivotal trial into a redesigned success, and how FDA approved Sunharbo to reduce recurrent stroke risk.

Więcej odcinków z kanału "Applied Clinical Trials"